Management and Treatment of Reversible Airway DiseaseByShellie K. Schoening, MBA, PharmD, RPhJuly 1st 2004
The Cost Effectiveness of Levalbuterol Versus Racemic AlbuterolByCampion Quinn, MD, FACP, MHAJuly 1st 2004
An Assessment of Therapeutic Regimens in the Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease and AsthmaByGrant H. Skrepnek, PhD, RPh,Stan V. Skrepnek, MDJuly 1st 2004
Epidemiology, Clinical and Economic Burden, and Natural History of Chronic Obstructive Pulmonary Disease and AsthmaByGrant H. Skrepnek, PhD, RPh,Stan V. Skrepnek, MDJuly 1st 2004
Issues and Challenges for Managed Care in the Treatment of Asthma and Chronic Obstructive Pulmonary DiseaseByShellie K. Schoening, MBA, PharmD, RPhJuly 1st 2004
